Medical
Radiopharma Infusion Device.
Adoption of radiopharmaceutical therapy was stalling on cost and complexity. We reframed an electronics problem as a mechanical one — expanding the addressable market and reaching a manufacturable design years ahead of plan.
241%
2 yrs
Reached a manufacturable design ahead of plan.
Razor-and-blade model — no capital purchase for the hospital; value comes through consumables.
The ask
“Develop an infusion system that enables radiopharmaceutical delivery — and solves the current barriers to adoption, development cost, and timeline.”
Client
Nucleus RadioPharma · nucleusrad.com
Industry
Medical / Radiopharma
Services
Concept reframing, design for manufacture
Engagement
Concept Gen → NPI
Timeline
Multi-phase
Additional Content
Problem
Adoption was blocked by real barriers: cost, integration complexity, regulatory risk, and the long timeline of building a custom shielded infusion pump.
Insight
We realized we didn’t need to build a shielded pump at all. Hospitals already have infusion pumps — so instead of replicating that, we could harness their existing flow-control source and pair it with a passive system that enables the radiopharmaceutical workflow.
Solution
A passive system that works with the hospital’s existing pump — so it:
- Harnesses flow control hospitals already have, rather than building a shielded pump
- Maintains radiation safety across the whole workflow — engineered around the three domains of protection: time, distance, and shielding
- Removes whole categories of electronics cost, tooling, and regulatory burden
- Delivers value as a consumable — no capital purchase, opening the device to more settings
“Ampersand has been the perfect partner to work on this very strategic project for Nucleus Radiopharma. I am impressed with how quickly the Ampersand team understood the problem statement and executed a very mature solution!”
Dominic Siewko — VP Radiation Safety & EHS, Nucleus RadioPharma